Congenital Abnormality
|
0.010 |
GeneticVariation
|
group |
BEFREE |
We suggested that this constituted a new multiple congenital anomaly-intellectual disability syndrome due to defects in CHD8 and/or SUPT16H.
|
30670789 |
2019 |
Difficulty sleeping
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
We investigated 25 individuals with CHD8 protein truncating variants (PTVs), including 10 previously unreported patients and found a male to female ratio of 2.7:1 (19:7) and a pattern of common features: macrocephaly (62.5%), tall stature (47%), developmental delay and/or intellectual disability (81%), ASDs (84%), sleep difficulties (50%), gastrointestinal problems (40%), and distinct facial features.
|
31001818 |
2019 |
Overgrowth Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
The CHD8 overgrowth syndrome: A detailed evaluation of an emerging overgrowth phenotype in 27 patients.
|
31721432 |
2019 |
Burnett Schwartz Berberian syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Two fetal genomes were found to harbor potentially detrimental variants in chromodomain helicase DNA binding protein 8 (<i>CHD8</i>) and LDL receptor-related protein 1 (<i>LRP1</i>), variations of which have been associated with autism spectrum disorder and keratosis pilaris atrophicans, respectively.
|
29545257 |
2018 |
Executive dysfunction
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the CHD2 gene have been linked to developmental delay, intellectual disability, autism and seizures, CHD8 mutations to autism and intellectual disability, whereas haploinsufficiency of CHD7 is associated with executive dysfunction and intellectual disability.
|
30277262 |
2018 |
Behavioral and psychological symptoms of dementia
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Our data suggest that CHD8 haploinsufficiency represents a specific subtype of ASD where neuropsychiatric symptoms are underpinned by long-range over-connectivity.
|
29668850 |
2018 |
Malignant neoplasm of breast
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
However, somatic mutations in CHD8 have been recently reported, making it an even more promising candidate, but further analysis of CHD8 in very large cohorts of families or case-control studies would be required to determine if it is a moderate-risk breast cancer susceptibility gene.
|
28840378 |
2017 |
Cardiovascular Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
The summary RR for high vs. low cheese consumption was 0.90 (95 % CI 0.82-0.99) for total CVD (7 studies, 8076 events), 0.86 (95 % CI 0.77-0.96) for CHD (8 studies, 7631 events), and 0.90 (95 % CI 0.84-0.97) for stroke (7 studies, 10,449 events), respectively.
|
27517544 |
2017 |
Microcephaly
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We sequenced 136 microcephaly or macrocephaly (Mic-Mac)-related genes and 158 possible ASD-risk genes in 536 Chinese ASD probands and detected 22 damaging de novo mutations (DNMs) in 20 genes, including CHD8 and SCN2A, with recurrent events.
|
28831199 |
2017 |
Cerebrovascular accident
|
0.010 |
Biomarker
|
group |
BEFREE |
The summary RR for high vs. low cheese consumption was 0.90 (95 % CI 0.82-0.99) for total CVD (7 studies, 8076 events), 0.86 (95 % CI 0.77-0.96) for CHD (8 studies, 7631 events), and 0.90 (95 % CI 0.84-0.97) for stroke (7 studies, 10,449 events), respectively.
|
27517544 |
2017 |
Craniofacial Abnormalities
|
0.010 |
GeneticVariation
|
group |
BEFREE |
We generated germline mutant mice with loss-of-function mutations in Chd8, a de novo mutation strongly associated with ASD, and demonstrate that these mice display hallmark ASD behaviors, macrocephaly, and craniofacial abnormalities similar to patient phenotypes.
|
28402856 |
2017 |
Breast Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
However, somatic mutations in CHD8 have been recently reported, making it an even more promising candidate, but further analysis of CHD8 in very large cohorts of families or case-control studies would be required to determine if it is a moderate-risk breast cancer susceptibility gene.
|
28840378 |
2017 |
Schizophrenia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
To better understand the phenotype associated with CHD8 mutations, we genotyped all CHD8 exons in carefully assessed cohorts of autism (n = 142), schizophrenia (SCZ; n = 143), and intellectual disability (ID; n = 94).
|
26789910 |
2016 |
Leukemia, Myelocytic, Acute
|
0.010 |
Biomarker
|
disease |
BEFREE |
Furthermore, BRD4, NSD3, and CHD8 colocalize across the AML genome, and each is released from super-enhancer regions upon chemical inhibition of BET bromodomains.
|
26626481 |
2015 |
Hematopoietic Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Although implicated as a risk factor in autism spectrum disorder and a tumor suppressor in prostate and lung cancer, the mechanism of CHD8's activity is still unclear and has never been studied in the context of hematopoietic malignancies.
|
26588464 |
2015 |
Precursor B-cell lymphoblastic leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
We identified the chromatin-modifying protein CHD8 as necessary for cell survival in a mouse model of BCR-Abl+ B-cell acute lymphoblastic leukemia.
|
26588464 |
2015 |
Neurodevelopmental Disorders
|
0.010 |
GeneticVariation
|
group |
BEFREE |
CHD8 mutations have been found in patients with neurodevelopmental disorders and macrocephaly.
|
25735987 |
2015 |
Colorectal Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We found that genes that regulate chromatin were mutated in CIMP1 CRCs; the highest rates of mutation were observed in CHD7 and CHD8, which encode members of the chromodomain helicase/adenosine triphosphate-dependent chromatin remodeling family.
|
24211491 |
2014 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The most interesting genes included in this deletion are CHD8, a chromodomain helicase DNA binding protein that is associated with autism spectrum disorders, and MMP14, a matrix metalloproteinase that has been linked to obesity and type 2 diabetes.
|
24243641 |
2014 |
Neoplasms
|
0.010 |
GeneticVariation
|
group |
BEFREE |
A prevalence screen showed that nonsilencing mutations in CHD7 and CHD8 occurred significantly more frequently in CIMP1 tumors (18 of 42 [43%]) than in CIMP2 (3 of 34 [9%]; P < .01) or CIMP-negative tumors (2 of 34 [6%]; P < .001).
|
24211491 |
2014 |
Obesity
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The most interesting genes included in this deletion are CHD8, a chromodomain helicase DNA binding protein that is associated with autism spectrum disorders, and MMP14, a matrix metalloproteinase that has been linked to obesity and type 2 diabetes.
|
24243641 |
2014 |
Malignant neoplasm of prostate
|
0.010 |
Biomarker
|
disease |
BEFREE |
CHD8 outperformed Gleason score and predicted biochemical failure within intermediate grade prostate cancers.
|
25499215 |
2014 |
Prostate carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Frequent disruption of chromodomain helicase DNA-binding protein 8 (CHD8) and functionally associated chromatin regulators in prostate cancer.
|
25499215 |
2014 |
Metastatic Prostate Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CHD8 expression was decreased in HGPIN, localized, and metastatic PCa compared to benign (P < .001).
|
25499215 |
2014 |
Metastasis from malignant tumor of prostate
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CHD8 expression was decreased in HGPIN, localized, and metastatic PCa compared to benign (P < .001).
|
25499215 |
2014 |